Clinic-epidemiological evaluation of ulcers in patients with leprosy sequelae and the effect of low level laser therapy on wound healing: a randomized clinical trial

Table 3 Demographics and baseline characteristics by treatment group¹.

Clinical data	Control group	Experimental group	pvalue
Gender (male/female)	9/3	9/2	1.0^a
Age, years	58.5 (19.2)	53.3 (15.2)	.42^b
Most common clinical form (%)	LL^# (92%)	LL^# (73%)	.31^a
Years since leprosy diagnostic	38.4 (16.0)	39.1 (15.7)	.91^b
Years free of M. leprae	14.2 (5.6)	14.3 (3.9)	.97^b
Ulcers duration (months)	71.7 (82.2)	123.3 (159.6)	.28^b
Ulcers area	5.3 (9.2)	4.2 (5.9)	.70^b
Ulcers depth	6.3 (5.4)	6.2 (5.1)	.96^b
PUSH score	9.7 (3.4)	9.6 (3.3)	.96^c
Adapted footwear usage	5 subjects	4 subjects	1.0^a

¹Values are means (SDs) unless otherwise indicated. ^# LL = Lepromatous leprosy.
^a As determined by Fisher's exact test.
^bAs determined by an independent 2-sample t test.
^cAs determined by the Mann-Whitney U test.

ISSN: 1471-2334